A Dose Finding Study to Treat Bone Tumor(s)

Clinical trial NCT06008483 · TERMINATED

Trial details

NCT number: NCT06008483
Sponsor: QSAM Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Bone Cancer Bone Tumor Solid Tumor Metastatic Cancer to the Bone Metastatic Tumor to the Bone

Start date: 2022-04-05
Primary completion: 2024-08-08
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.